uBiome, a San Francisco startup that sells commercial tests that use DNA sequencing to identify what microbes are in a person’s stool or, for one test, in the vagina, has raised $83 million from venture capitalists to fund an entrée into drug development.
Why Former Novartis CEO Joe Jimenez Joined A Microbiome Startup’s Board
